Answers are grounded in this paper and cite their sources.
In order to understand the change of MMP-2 and MMP-9 in dogs with mammary gland tumor (MGT), theactivity of MMP-2 and MMP-9 in plasma samples, MGT tissues and near by normal mammary gland tissues wereevaluated by gelatin zymography. The levels of MMP-2 and MMP-9 were significantly higher in tumor tissues thanthose in normal gland tissues (p<0.05). Plasma MMP-9 levels in malignant cases were higher than those in benign(p=0.15) and non-tumor cases (p<0.05). Likewise, plasma MMP-2 levels in malignant MGT cases were higher thannon-tumor (p<0.01) and benign cases (p=0.54). Furthermore, plasma MMP-9 levels were reflected and positivelycorrelated with MMP-9 in tumor tissues (r=0.78, p=0.02), but not MMP-2. Our results indicated that the MMP-2 andMMP-9 levels are associated with tumor malignancy, and plasma MMP-9 activity can become a potential marker bothin follow-up and prognosis of canine MGT patients.
No takes yet. Share an insight, caveat, or question.
Shia et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: